Quantifying HTLV-I Dynamics

Overview

Journal Immunol Cell Biol

Publisher Wiley

Specialties Allergy & Immunology
Cell Biology

Date 2007 Mar 21

PMID 17372609

Citations 13

Authors

Becca Asquith

Charles R M Bangham

Affiliations

Soon will be listed here.

Abstract

Despite significant advances in our understanding of the immune response to persistent viruses like human T-cell lymphotropic virus type I (HTLV-I), many important questions remain unanswered. Mathematical modelling enables us to interpret and synthesise diverse experimental data in new ways and thus can contribute to our understanding. Here, we review recent advances in mathematical modelling of HTLV-I infection and illustrate how mathematics has enabled us to identify factors that determine an individual's viral burden and risk of developing HTLV-I-associated diseases.

Citing Articles

Stability of a discrete HTLV-1/SARS-CoV-2 dual infection model.

Alshaikh M, Aljahdali A Heliyon. 2024; 10(7):e28178.

PMID: 39668935 PMC: 11636898. DOI: 10.1016/j.heliyon.2024.e28178.

Modeling and analysis of a within-host HIV/HTLV-I co-infection.

Elaiw A, AlShamrani N Bol Soc Mat Mex. 2021; 27(2):38.

PMID: 33814640 PMC: 8005865. DOI: 10.1007/s40590-021-00330-6.

Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination.

Akondy R, Johnson P, Nakaya H, Edupuganti S, Mulligan M, Lawson B Proc Natl Acad Sci U S A. 2015; 112(10):3050-5.

PMID: 25713354 PMC: 4364194. DOI: 10.1073/pnas.1500475112.

Viral kinetic modeling: state of the art.

Canini L, Perelson A J Pharmacokinet Pharmacodyn. 2014; 41(5):431-43.

PMID: 24961742 PMC: 4210370. DOI: 10.1007/s10928-014-9363-3.

HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection.

Bangham C, Cook L, Melamed A Semin Cancer Biol. 2013; 26:89-98.

PMID: 24316494 PMC: 4062949. DOI: 10.1016/j.semcancer.2013.11.003.